Tag: Lung Cancer
-
IFITM3-MET Interaction Drives Osimertinib Resistance in EGFR-Mutant NSCLC
Overview: A New Mechanism Behind Osimertinib Resistance in EGFR-Mutant NSCLC Osimertinib has transformed the treatment landscape for patients with EGFR-mutant non-small cell lung cancer (NSCLC). Yet resistance remains a major hurdle. A recent study identifies a non-genetic mechanism: the membrane protein IFITM3 interacts with MET to activate the PI3K-AKT signaling axis, enabling tumor cells to…
-
Could COVID Vaccines Help Fight Cancer? What the New Findings Mean
Could the COVID-19 vaccine help in the fight against cancer? Emerging research is stirring new questions about how COVID-19 vaccines, particularly mRNA vaccines, might interact with cancer therapies. A study analyzing more than 1,000 patient records suggests that receiving a COVID-19 mRNA vaccine within 100 days of starting immunotherapy was associated with longer survival for…
-
Could COVID mRNA Vaccines Help Fight Cancer? New US Study Sparks Hope—and Caution
Can COVID mRNA vaccines boost cancer treatment? Recent research from the United States has sparked interest in a surprising possible benefit of the COVID-19 mRNA vaccine: enhancing the effectiveness of cancer immunotherapy. In a retrospective analysis of more than 1,000 patient records, researchers found that patients with advanced lung cancer or metastatic skin cancer (melanoma)…
-
Could COVID Vax Fight Cancer? New Findings Surprise on Immunotherapy Outcomes
Can a COVID-19 Vaccine Help Treat Cancer? Recent research from the United States has sparked interest in whether COVID-19 vaccines, particularly mRNA vaccines, might influence cancer outcomes when given alongside immunotherapy. In a retrospective analysis of more than 1,000 patients with advanced lung cancer or metastatic melanoma, researchers found that those who received a COVID-19…
-
MEDLEY Study Aims to Boost Early Detection of Lung Cancer with Low-Dose CT Scans
New study aims to revolutionize how we detect lung cancer early A major new study, currently recruiting across several UK regions, could transform how doctors identify lung cancer at an earlier, more treatable stage. The MEDLEY trial brings together researchers from the Universities of Leeds, Sheffield, Exeter and Nottingham, along with Queen Mary University of…
-
Could low-dose CT scans replace chest X-rays for early lung cancer detection? MEDLEY study underway
New study aims to improve early detection of lung cancer A major new study, MEDLEY, is underway with recruitment in several UK cities. The project, funded by the National Institute for Health Research (NIHR), seeks to determine whether low-dose computed tomography (CT) scans can improve the early detection of lung cancers compared with the traditional…
-
New MEDLEY Study Could Push Early Lung Cancer Detection Forward
Overview: A Major Step Toward Earlier Lung Cancer Detection A large, multi-institution study known as MEDLEY has begun recruiting participants across several UK cities, including Leeds, Bath, Hull and Stoke-on-Trent. Funded by the National Institute for Health Research (NIHR), the trial seeks to determine whether low-dose CT (LDCT) scans can identify lung cancers earlier than…
-
AI and Data Drive Alberta Cancer Care: Dr. Omar Khan’s Vision for a Healthier Future
Introduction: A physician who sees data as a patient ally In Calgary, Alberta, Dr. Omar Khan is turning data into a core component of cancer care. A medical oncologist who treats breast cancer and sarcoma at the Arthur J.E. Child Comprehensive Cancer Centre, Khan has long believed that artificial intelligence and advanced analytics will transform…
-
Google Maps for Lung Cancer: A New AI-Driven Path to Precision Treatment
Revolutionizing Lung Cancer Treatment with a Google Maps Approach Researchers are adopting a groundbreaking method likened to a “Google maps” of cancer to guide treatment decisions for non-small cell lung cancer (NSCLC). In a multi-institution study led by Associate Professor Arutha Kulasinghe from the Frazer Institute at the University of Queensland, alongside teams at Yale…
-
Google-style Maps for NSCLC: AI-Driven Precision Lung Cancer Treatment
A New Era in Lung Cancer Treatment Researchers from the University of Queensland’s Frazer Institute and Yale University have unveiled a groundbreaking approach to treating non-small cell lung cancer (NSCLC). By combining artificial intelligence with spatial biology, the team analyzed tumors from 234 NSCLC patients across three cohorts in Australia, the United States, and Europe.…